Iaso Ventures catalyzes biodigital innovation in next-gen life sciences by investing in game-changing startups that aim to cure disease and improve patient lives. The firm backs data-driven enabling technologies and platforms that support therapeutic development, leveraging an investor-operator DNA and a collaborative, expert network to accelerate growth and value creation in healthcare. Their work centers on grounding cutting-edge scientific advances in real-world patient outcomes, with a strategic ecosystem of partners across the life sciences landscape.